Insufficient scRNA-seq data for expression of ADM2 at single-cell level.
Insufficient scRNA-seq data for expression of ADM2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 99% | 1504.82 | 88 / 89 | 91% | 28.36 | 820 / 901 |
pancreas | 100% | 1561.57 | 328 / 328 | 87% | 13.53 | 154 / 178 |
prostate | 87% | 555.81 | 212 / 245 | 99% | 32.21 | 498 / 502 |
thymus | 100% | 2051.33 | 652 / 653 | 83% | 19.94 | 503 / 605 |
liver | 94% | 435.65 | 212 / 226 | 71% | 12.07 | 290 / 406 |
stomach | 75% | 474.53 | 269 / 359 | 80% | 9.99 | 228 / 286 |
lung | 63% | 175.44 | 367 / 578 | 81% | 11.95 | 934 / 1155 |
breast | 51% | 90.55 | 235 / 459 | 86% | 13.09 | 963 / 1118 |
intestine | 47% | 193.65 | 456 / 966 | 83% | 9.43 | 436 / 527 |
esophagus | 37% | 200.73 | 540 / 1445 | 77% | 9.42 | 140 / 183 |
spleen | 98% | 240.07 | 236 / 241 | 0% | 0 | 0 / 0 |
skin | 43% | 312.36 | 781 / 1809 | 39% | 4.85 | 186 / 472 |
tonsil | 0% | 0 | 0 / 0 | 76% | 11.02 | 34 / 45 |
uterus | 7% | 18.99 | 12 / 170 | 57% | 6.94 | 261 / 459 |
lymph node | 0% | 0 | 0 / 0 | 62% | 4.89 | 18 / 29 |
bladder | 14% | 19.29 | 3 / 21 | 47% | 5.12 | 238 / 504 |
peripheral blood | 58% | 163.14 | 537 / 929 | 0% | 0 | 0 / 0 |
ovary | 1% | 1.01 | 1 / 180 | 42% | 3.15 | 181 / 430 |
eye | 0% | 0 | 0 / 0 | 23% | 1.68 | 18 / 80 |
adrenal gland | 13% | 35.99 | 34 / 258 | 7% | 0.70 | 17 / 230 |
adipose | 12% | 22.65 | 141 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 5% | 8.65 | 64 / 1335 | 0% | 0 | 0 / 0 |
brain | 1% | 1.59 | 31 / 2642 | 3% | 0.29 | 21 / 705 |
heart | 4% | 6.60 | 35 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.09 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007631 | Biological process | feeding behavior |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0001525 | Biological process | angiogenesis |
GO_0003073 | Biological process | regulation of systemic arterial blood pressure |
GO_0006468 | Biological process | protein phosphorylation |
GO_0045776 | Biological process | negative regulation of blood pressure |
GO_0010460 | Biological process | positive regulation of heart rate |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0005576 | Cellular component | extracellular region |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005179 | Molecular function | hormone activity |
Gene name | ADM2 |
Protein name | Protein ADM2 (Intermedin) [Cleaved into: Adrenomedullin-2 (AM2) (Intermedin-long) (IMDL); Intermedin-short (IMDS)] |
Synonyms | AM2 |
Description | FUNCTION: [Adrenomedullin-2]: May play a role as physiological regulators of gastrointestinal, cardiovascular bioactivities mediated by the CALCRL/RAMPs receptor complexes. Activates the cAMP-dependent pathway. .; FUNCTION: [Intermedin-short]: May play a role as physiological regulators of gastrointestinal, cardiovascular bioactivities mediated by the CALCRL/RAMPs receptor complexes. Activates the cAMP-dependent pathway. . |
Accessions | ENST00000395737.2 Q7Z4H4 ENST00000395738.2 |